ASPG and acute lymphoblastic leukemia: Conversely, in patients with ALL, weight gain begins during induction therapy, which is the result of exposure to glucocorticoids and asparaginase, unhealthy diets, and lack of activity, and continues even after the end of therapy [23, 24].